Dose-enhanced combined priming regimens for refractory acute myeloid leukemia and middle-and-high-risk myelodysplastic syndrome: a single-center, retrospective cohort study

Dose-enhanced combined priming regimens for refractory acute myeloid leukemia and middle-and-high-risk myelodysplastic syndrome: a single-center, retrospective cohort study

Xiaorong Ma, Jin Wang, Yan Xu, Wanggang Zhang, Jie Liu, Xingmei Cao, Aili He, Fangxia Wang, Liufang Gu, Bo Lei, Jianli Wang Department of Hematology, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, People’s Republic of China Objective: To assess ch...

Full description

Bibliographic Details
Main Authors: Ma X, Wang J, Xu Y, Zhang W, Liu J, Cao X, He A, Wang F, Gu L, Lei B
Format: Article
Language:English
Published: Dove Medical Press 2016-06-01
Series:OncoTargets and Therapy
Subjects:
priming chemotherapy
acute myeloid leukemia
myelodysplastic syndrome
B7.1
Online Access:https://www.dovepress.com/dose-enhanced-combined-priming-regimens-for-refractory-acute-myeloid-l-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/dose-enhanced-combined-priming-regimens-for-refractory-acute-myeloid-l-peer-reviewed-article-OTT

Similar Items